Clinical trial
Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.
NCT00394680 · Shaare Zedek Medical Center, Other · Completed
Key facts
| NCT number | NCT00394680 |
|---|---|
| Title | Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact. |
| Official title | Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact. |
| Lead sponsor | Shaare Zedek Medical Center, Other |
| Collaborators | Hebrew University of Jerusalem |
| Status | Completed |
| Study type | Observational |
| Conditions | Coronary Arteriosclerosis, Angina Unstable, Myocardial Infarction |
| Enrollment | 700 |
| Start date | Nov 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Nov 1, 2006 |
| Last update posted | May 27, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: